REVB — Revelation Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Revelation Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12 | -10.8 | -0.12 | -15 | -8.91 |
| Depreciation | |||||
| Non-Cash Items | 0.523 | 0.316 | -8.17 | 0.112 | 0.623 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.356 | -0.731 | 0.982 | -3.42 | -0.006 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -11.1 | -11.2 | -7.29 | -18.3 | -8.27 |
| Capital Expenditures | -0.132 | 0 | — | -0.019 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.132 | 0 | — | -0.019 | 0 |
| Financing Cash Flow Items | — | 11.5 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8 | 15.2 | 14 | 12.8 | 12.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.22 | 3.98 | 6.74 | -5.49 | 4.2 |